Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 8/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | PNMT | P11086 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27147 | 0.91 | TDP1 (0.48) | TDP1TAAR1TSHRTRPA1ALDH1A1 | |
| SCHEMBL32679673 | 0.91 | TDP1 (0.48) | TDP1TAAR1TSHRTRPA1ALDH1A1 | |
| SCHEMBL28791116 | 0.89 | TDP1 (0.46) | TDP1TAAR1TSHRTRPA1ALDH1A1 | |
| SCHEMBL7886758 | 0.87 | TDP1 (0.44) | TDP1TAAR1TSHRALDH1A1GABRA1 | |
| SCHEMBL6267374 | 0.87 | TDP1 (0.44) | TDP1TAAR1TSHRTRPA1ALDH1A1 | |
| SCHEMBL11690539 | 0.87 | APOBEC3G (0.44) | TDP1TAAR1TSHRPTPN1GSK3B | |
| SCHEMBL8110945 | 0.87 | TDP1 (0.44) | TDP1TAAR1TSHRTRPA1ALDH1A1 | |
| SCHEMBL17355120 | 0.87 | TDP1 (0.44) | TDP1TAAR1TSHRTRPA1ALDH1A1 | |
| SCHEMBL6481917 | 0.87 | GABRA1 (0.48) | TDP1TAAR1TSHRPTPN1GSK3B | |
| SCHEMBL27742253 | 0.87 | TDP1 (0.44) | TDP1TAAR1TSHRTRPA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2010530439-A | — | — | 2010-09-09 | — | — | JP | claimed |
| EP-2115059-A1 | FLAME RETARDANT COMPOSITION FOR USE IN STYRENICS | CHEMTURA CORPORATION (US) | 2009-11-11 | — | — | EP | claimed |
| WO-2008127753-A1 | FLAME RETARDANT COMPOSITION FOR USE IN STYRENICS | CHEMTURA CORPORATION (US) | 2008-10-23 | — | — | WO | claimed |
| EP-1393394-B1 | CONDUCTIVE POLYAMINE-BASED ELECTROLYTE | UNIV OKLAHOMA (US) | 2006-11-22 | — | — | EP | claimed |
| US-4774302-A | BROMINE, IODINE CONTAINING AROMATIC CATALYSTS | NIPPON MEKTRON LIMITED (JP) | 1988-09-27 | — | — | US | claimed |
| US-20250179691-A1 | MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO CARBOHYDRATE-BINDING MONOCLONAL ANTIBODY FAMILY PGT128 | BRANDEIS UNIVERSITY (US) | 2025-06-05 | — | — | US | disclosed |
| US-12247320-B2 | Multivalent glycopeptides that tightly bind to carbohydrate-binding monoclonal antibody family PGT128 | BRANDEIS UNIVERSITY (US) | 2025-03-11 | — | — | US | disclosed |
| WO-2022261257-A1 | STAPLED PEPTIDES AND METHODS THEREOF | FOG PHARMACEUTICALS, INC. (US) | 2022-12-15 | — | — | WO | disclosed |
| CN-114956933-A | Marker containing isotope oxygen atom and preparation method and application thereof | 清华大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-111517902-B | Aerobic oxidation system containing sulfinic acid, sulfonic acid or derivatives thereof and photo-oxidation promoting method thereof | 清华大学 | 2022-06-14 | — | — | CN | disclosed |
| US-20220090055-A1 | MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO CARBOHYDRATE-BINDING MONOCLONAL ANTIBODY FAMILY PGT128 | BRANDEIS UNIVERSITY | 2022-03-24 | — | — | US | disclosed |
| CN-111517902-A | Aerobic oxidation system containing sulfinic acid, sulfonic acid or derivatives thereof and photo-oxidation promoting method thereof | 清华大学 | 2020-08-11 | — | — | CN | disclosed |
| WO-2008127753-A1 | FLAME RETARDANT COMPOSITION FOR USE IN STYRENICS | CHEMTURA CORPORATION (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20050234199-A1 | Acrylic block copolymer and thermoplastic resin composition | KANEKA CORPORATION (JP) | 2005-10-20 | — | — | US | disclosed |
| US-4824977-A | HYDROFORMYLATION | EASTMAN KODAK COMPANY (US) | 1989-04-25 | — | — | US | disclosed |
| US-4774362-A | HYDROFORMYLATION CATALYSTS FOR REACTION OF OLEFINS | EASTMANK KODAK COMPANY (US) | 1988-09-27 | — | — | US | disclosed |
| US-4642315-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1987-02-10 | — | — | US | disclosed |
| US-4587234-A | HYPOTENSIVES | E. R. SQUIBB & SONS, INC. (US) | 1986-05-06 | — | — | US | disclosed |
| US-4499079-A | ENZYME INHIBITORS, HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1985-02-12 | — | — | US | disclosed |
| US-3939084-A | Functional fluid compositions containing substituted pyrimidines | MONSANTO COMPANY (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250179691-A1 | MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO CARBOHYDRATE-BINDING MONOCLONAL ANTIBODY FAMILY PGT128 | CSGALNACT1, STT3A, STT3B | TDP1 4433/4885TAAR1 4873/4885TSHR 2499/4885 |
| US-12247320-B2 | Multivalent glycopeptides that tightly bind to carbohydrate-binding monoclonal antibody family PGT128 | CSGALNACT1, STT3A, GALNT14 | TDP1 4359/4885TAAR1 4883/4885TSHR 4155/4885 |
| US-20220090055-A1 | MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO CARBOHYDRATE-BINDING MONOCLONAL ANTIBODY FAMILY PGT128 | CSGALNACT1, STT3A, GALNT14 | TDP1 4359/4885TAAR1 4883/4885TSHR 4155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.